Glycosylative inactivation of chalcomycin and tylosin by a clinically isolated Nocardia asteroides strain

Journal of Antibiotics

Volumn 54, Issue 2, 2001, Pages 157-165

  Morisaki, N ^a   Hashimoto, Y ^a   Furihata, K ^a   Yazawa, K ^a   Tamura, M ^a   Mikami, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

18 DIHYDRO 2' O PHOSPHORYLMIDECAMYCIN; 18 DIHYDRO 2' O PHOSPHORYLROKITAMYCIN; 18 DIHYDROMIDECAMYCIN; 18 DIHYDROROKITAMYCIN; 2' O PHOSPHORYLERYTHROMYCIN; 2' [O(BETA DEXTRO GLUCOPYRANOSYL)]CHALCOMYCIN; 2' [O(BETA DEXTRO GLUCOPYRANOSYL)]ERYTHROMYCIN; 2' [O(BETA DEXTRO GLUCOPYRANOSYL)]TYLOSIN; 20 DIHYDRO 2' [O(BETA DEXTRO GLUCOPYRANOSYL)]TYLOSIN; AGAR; ANTIBIOTIC AGENT; BICARBONATE; CARBOHYDRATE DERIVATIVE; CHALCOMYCIN; CHIP 0339; DRUG METABOLITE; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; HYDROXYL GROUP; LACTONE DERIVATIVE; MACROLIDE; METHANOL; MIDECAMYCIN; ORGANIC COMPOUND; ROKITAMYCIN; TIP 0339 1; TIP 0339 2; TYLOSIN; TYLOSIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG INACTIVATION; DRUG STRUCTURE; GLYCOSYLATION; MASS SPECTROMETRY; NOCARDIA ASTEROIDES; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STRUCTURE ANALYSIS;

NOCARDIA; NOCARDIA ASTEROIDES; NOCARDIA NOVA;

EID: 0035085590     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.54.157     Document Type: Article

References (33)

1. Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species
2. Structural elucidation of rokitamycin, midecamycin and erythromycin metabolites formed by pathogenic Nocardia
3. The structure of chalcomycin
4. Chalcomycin: Single-crystal X-ray crystallographic analysis; Biosynthetic and stereochemical correlations with other polyoxo macrolide antibiotics
5. X-ray crystallography of protylonolide and absolute configuration of tylosin
6. Novel fermentation products from Streptomyces fradiae: X-ray crystal structure of 5-O-mycarosyltylactone and proof of the absolute configuration of tylosin
7. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy
8. MLEV-17-Based two-dimensional homonuclear magnetization transfer spectroscopy
9. 15N spectroscopy
10. Sensitivity improvement in proton-detected two-dimensional heteronuclear relay spectroscopy
11. In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262)
12. Studies on a novel cytocidal antibiotic, trienomycin A. Taxonomy, fermentation, isolation, and physiological and biological characteristics
13. Carbon-13 nuclear magnetic resonance spectral analysis of 16-membered macrolide antibiotics
14. Elucidation of structure of novel macrolide antibiotics produced by mutant strains of Streptomyces fradiae
15. Proton and carbon chemical shift assignment and dynamic investigation of the macrolide antibiotic tylosin
16. Isolation of decomposition products of tylosin using liquid chromatography
17. Proton and carbon chemical shift assignment and solution-state conformation of the macrocyclic ring in the macrolide antibiotic tylosin in aprotic solvents
18. Configurational and conformational influences on the carbon-13 chemical shifts of some carbohydrates
19. 13C magnetic resonance spectra of aldoses and derived methyl glycosides
20. 13C] enriched monosaccharides. Signal assignments and orientational dependence of geminal and vicinal carbon-carbon and carbon-hydrogen spin-spin coupling constants
21. Role of glycosylation and deglycosylation in biosynthesis of and resistance to oleandomycin in the producer organism, Streptomyces antibioticus
22. Cloning and characterization of two genes from Streptomyces lividans that confer inducible resistance to lincomycin and macrolide antibiotics
23. Glycosylation of macrolide antibiotics in extracts of Streptomyces lividans
24. Resistance to macrolides and lincosamides in Streptomyces lividans and to aminoglycosides in Micromonospora purpurea
25. Microbial glycosylation of erythromycin A
26. Microbial glycosylation of macrolide antibiotics by Streptomyces hygroscopicus ATCC 31080 and distribution of a macrolide glycosyl transferase in several Streptomyces strains
27. Structural analysis of oligosaccharide chains of glycolipids by two-dimensional NMR
28. Brasilicardin A. A novel tricyclic metabolite with potent immunosuppressive activity from actinomycete Nocardia brasiliensis
29. Brasilidine A, a new cytotoxic isonitrile-containing indole alkaloid from the actinomycete Nocardia brasiliensis
30. A new antifungal macrolide component, brasilinolide B, produced by Nocardia brasiliensis
31. Production of nocardicyclines by clinical isolates of Nocardia pseudobrasiliensis and in vivo antitumor activity of the antibiotic
32. Production of erythromycin E by pathogenic Nocardia brasiliensis